| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000046121 |
| Receipt No. | R000049433 |
| Scientific Title | Study on vascular lesions in retinal diseases using optical coherence tomography Angiography |
| Date of disclosure of the study information | 2021/11/19 |
| Last modified on | 2021/11/19 (Ver. 1) |
| Basic information | ||
| Public title | Study on vascular lesions in retinal diseases using optical coherence tomography Angiography | |
| Acronym | Study on vascular lesions in retinal diseases using optical coherence tomography Angiography | |
| Scientific Title | Study on vascular lesions in retinal diseases using optical coherence tomography Angiography | |
| Scientific Title:Acronym | Study on vascular lesions in retinal diseases using optical coherence tomography Angiography | |
| Region |
|
|
| Condition | |||
| Condition | Diabetic retinopathy,Retinal vein occlusion,Age-related macular degeneration,Other retinopathy | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | By performing fundus photography using the optical coherence tomography (OCTA), the retinal vascular network structure can be visualized non-invasively.The purpose of this study is to photograph the fundus of healthy subjects and patients with retinal diseases, compare OCTA with conventional OCT images, fluorescent fundus angiography images, etc., evaluate the superiority of OCTA, and evaluate its clinical usefulness.Is to evaluate comprehensively. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Evaluation of retinal structure, retinal blood vessel shape, and retinal blood vessel perfusion by comparison with conventional fluorescence fundus angiography and OCT.
Specifically, the network thickness, vascular density, area of foveal avascular field and non-perfused area, visibility of retinal capillary aneurysm and retinal / choroidal neovascularization will be examined. |
| Key secondary outcomes | Correlation between Primary endpoint and the following clinical findings.Clinical findings: Information on age, gender, examination history and medical history (maximum corrected visual acuity, intraocular pressure, slit lamp microscopy, inversion ophthalmoscope examination, fundus photography, static quantitative visual field examination, conventional OCT analysis data, retinal electrocardiographyFigure, blood pressure, blood test) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | 120 people 240 eyes
Intervention content for individual subjects:Instill Midorin P and Neocinedin before using Angiography Dose:0.2ml frequency:Once |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Those who fully understand this research plan and can give their consent
(2) Those who are 20 years old or older at the time of obtaining consent. (3) Those with diabetic retinopathy, branch retinal vein occlusion, age-related macular degeneration or other retinopathy |
|||
| Key exclusion criteria | (1) Those who have a history of hypersensitivity to mydriatic agents, those who have a predisposition to increased intraocular pressure such as angle-closure glaucoma and narrow-angle angle, and those who have a history of increased blood pressure or palpitation due to mydriatic agents.Someone
(2) Those who have a shallow anterior chamber by slit lamp microscopy (3) Those who are judged to be difficult to take due to cataract by slit lamp microscopy |
|||
| Target sample size | 240 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | National Hospital Organization Kyushu Medical Center | ||||||
| Division name | Ophthalmology | ||||||
| Zip code | 8108563 | ||||||
| Address | 1-8-1, Jigyohama, Chuo-ku, Fukuoka | ||||||
| TEL | 092-852-0700 | ||||||
| snakao@med.kyushu-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | National Hospital Organization Kyushu Medical Center | ||||||
| Division name | Ophthalmology | ||||||
| Zip code | 810-8563 | ||||||
| Address | 1-8-1, Jigyohama, Chuo-ku, Fukuoka | ||||||
| TEL | 092-852-0700 | ||||||
| Homepage URL | http://kyumed.jp/chiken/index.html | ||||||
| snakao@med.kyushu-u.ac.jp | |||||||
| Sponsor | |
| Institute | National Hospital Organization Kyushu Medical Center
Ophthalmology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of education |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kyushu Medical Center Clinical Research Center Clinical Trial Support Center |
| Address | 1-8-1, Jigyohama, Chuo-ku, Fukuoka |
| Tel | 092-852-0700 |
| 602-rinri@mail.hosp.go.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 独立行政法人 国立病院機構 九州医療センター(福岡県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 25 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049433 |